Do cardiac risk factors affect the homocysteine and asymmetric dimethylarginine relationship in patients with coronary artery diseases?

Isiklar Ö. Ö., BARUTÇUOĞLU B., Kabaroglu C., Mutaf I., Ozmen D., Bayindir O., ...Daha Fazla

CLINICAL BIOCHEMISTRY, cilt.45, sa.16-17, ss.1325-1330, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 16-17
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1016/j.clinbiochem.2012.06.024
  • Dergi Adı: CLINICAL BIOCHEMISTRY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1325-1330
  • Anahtar Kelimeler: Atherosclerosis, Cardiovascular disease, Risk factors, NITRIC-OXIDE SYNTHASE, ACUTE MYOCARDIAL-INFARCTION, ENDOTHELIAL DYSFUNCTION, S-ADENOSYLMETHIONINE, INSULIN-RESISTANCE, OXIDATIVE STRESS, HEART-FAILURE, PLASMA-LEVELS, ADMA LEVELS, B-VITAMINS
  • Eskişehir Osmangazi Üniversitesi Adresli: Hayır

Özet

Objectives: Elevated homocysteine (Hcy) concentrations have been shown to be a risk factor for atherosclerotic vascular disease and thrombosis. Increased asymmetric dimethylarginine (ADMA) levels have been implicated in the pathogenesis of numerous conditions affecting the cardiovascular system. In this study, the influence of cardiovascular risk factors and other variables on Hcy and ADMA relationship in patients with coronary artery disease (CAD) was investigated.